SCHEMBL6948586

SCHEMBL6948586

Cc1nc(N2CCc3ccccc3C(=O)C2)c([N+](=O)[O-])c(=O)[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYMS P04818 1/20 0.44
MEN1 O00255 5/20 0.37
KMT2A Q03164 5/20 0.37
POLB P06746 2/20 0.37
NPY5R Q15761 1/20 0.36
RAB9A P51151 2/20 0.35
HTT P42858 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPT P10636 6/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
NPC1 O15118 1/20 0.34
GPR55 Q9Y2T6 1/20 0.34
EED O75530 1/20 0.34
ALDH1A1 P00352 2/20 0.33
PKM P14618 1/20 0.33
MAPK1 P28482 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6949298 0.79 GRIN1 (0.37) TYMSMEN1KMT2APOLBRAB9A
SCHEMBL6952355 0.76 KMT2A (0.40) MEN1KMT2ARAB9ASMN1; SMN2CYP1A2
SCHEMBL6435436 0.76 MAPT (0.35) MEN1KMT2APOLBRAB9AHTT
SCHEMBL6955056 0.76 PNMT (0.40) TYMSMEN1KMT2AHTTSMN1; SMN2
SCHEMBL4417547 0.76 MAPT (0.58) MEN1KMT2APOLBRAB9ASMN1; SMN2
SCHEMBL6950817 0.75 TYMS (0.44) TYMSMEN1KMT2APOLBRAB9A
SCHEMBL6947740 0.75 TYMS (0.44) TYMSMEN1KMT2APOLBHTT
SCHEMBL6953047 0.75 MAPT (0.38) MEN1KMT2ARAB9AHTTSMN1; SMN2
SCHEMBL4420238 0.75 MAPT (0.42) MEN1KMT2ASMN1; SMN2MAPTCYP1A2
SCHEMBL6951060 0.75 HTT (0.44) TYMSMEN1KMT2ARAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed